The global cisplatin injection market is expected to grow at a significant CAGR during the forecast period. Cisplatin injection is an anti-cancer chemotherapeutic medicine that is used to treat lung cancer, brain tumours, breast cancer, bladder cancer, ovarian cancer, cervical cancer, and esophageal cancer, among other malignancies. IV treatment is administered by injecting directly into a vein. The market is driven by an increase in cancer prevalence. As per Cancer Research UK, the incidence of cancer is estimated to reach 62% during 2018-2040 across the globe. Bladder cancer is considered as the fourth common cancer in men whereas it is least common cancer in women.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cisplatin-injection-market
As per the American Cancer Society, there will be an estimated 80,470 of new cases in the US in 2019. Out of this, 61,700 new cases will be associated with male and 18,770 will be associated with the female. The major factors that cause a high incidence of bladder cancer are increased geriatric population, increased consumption of alcohol and increased smoking. An overall increment of 31% has been observed in bladder cancer globally during 2005-2015.
As per the estimations by World Health Organization (WHO), in 2020, there were a total of 281,491 breast cancer cases in North America, and it is expected to reach nearly 343,426 by 2040. The US accounted for the 253,456 new cancer cases in 2020, which was 11.1% of the total cancer cases, which are expected to reach nearly 307,479 by 2040, whereas the new cancer cases registered in Canada were 28,026, which are expected to reach nearly 35,026 by 2040. Similar to the treatment of other malignancies, cisplatin is used as the first-line agent for breast cancer treatment, which in turn, is driving the market growth.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Pfizer Inc., Sanofi SA, and Teva Pharmaceuticals Industries Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Cisplatin Injection Market Report by Segment
By Product Type
- 50 ML
- 100 ML
- 200 ML
By Application
- NSCLC
- Ovarian Cancer
- Testicular Cancer
- Others
A full report of Cisplatin Injection Market is available at: https://www.omrglobal.com/industry-reports/cisplatin-injection-market
Cisplatin Injection Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Pfizer Inc.
- Sanofi SA
- Teva Pharmaceuticals Industries Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
